E-LIB Suche - Ergebnisse für: Mitchell, Leah A.

1

Centralizing a controlled substance compliance and drug div..:

Neal, Danielle ; Mitchell, Leah ; Mieure, Katherine
American Journal of Health-System Pharmacy. 80 (2023) 15 - p. 1018-1025 , 2023

Link: https://doi.org/10.1093/..

2

Movement-specific signaling is differentially distributed a..:

Currie, Stephen P. ; Ammer, Julian J. ; Premchand, Brian...
Cell Reports. 39 (2022) 6 - p. 110801 , 2022

Link: https://doi.org/10.1016/..

3

Analyzing the effects of observation function selection in ..:

Mitchell, Leah ; Arnold, Andrea
Mathematical Biosciences. 339 (2021) - p. 108655 , 2021

Link: https://doi.org/10.1016/..

4

Manager Support for Wellness Champions: A Case Study for Co..:

Mitchell, Leah ; Amaya, Megan ; Battista, Lauren...
Workplace Health & Safety. 69 (2020) 3 - p. 100-108 , 2020

Link: https://doi.org/10.1177/..

5

PD-L1 checkpoint blockade delivered by retroviral replicati..:

Mitchell, Leah A. ; Yagiz, Kader ; Hofacre, Andrew...
Oncotarget. 10 (2019) 23 - p. 2252-2269 , 2019

Link: https://doi.org/10.18632..

6

A Retroviral Replicating Vector Encoding Cytosine Deaminase..:

Yagiz, Kader ; Rodriguez-Aguirre, Maria E. ; Lopez Espinoza, Fernando...
Molecular Therapy - Oncolytics. 8 (2018) - p. 14-26 , 2018

Link: https://doi.org/10.1016/..

7

CADD-23. PD-L1 CHECKPOINT BLOCKADE USING A SINGLE-CHAIN VAR..:

Lin, Amy ; Yagiz, Kader ; Hofacre, Andrew...
Neuro-Oncology. 20 (2018) suppl_6 - p. vi280-vi280 , 2018

Link: https://doi.org/10.1093/..

8

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits..:

Lin, Amy H. ; Twitty, Christopher G. ; Burnett, Ryan...
Molecular Therapy - Nucleic Acids. 6 (2017) - p. 221-232 , 2017

Link: https://doi.org/10.1016/..

9

ATIM-25. IMMUNOLOGICAL ACTIVATION IN RESPONDING PATIENTS WI..:

Ostertag, Derek ; Accomando, William ; Hogan, Daniel...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi31-vi32 , 2017

Link: https://doi.org/10.1093/..

10

Effect of Hydrogen Sulfide‐Releasing Compounds on Aqueous H..:

Robinson, Jenaye ; Mitchell, Leah ; Ngele, Kalu...
The FASEB Journal. 31 (2017) S1 - p. , 2017

Link: https://doi.org/10.1096/..

11

TMIC-42. TOCA 511 AND 5-FC INDUCES T CELL-MEDIATED ANTITUMO..:

Jolly, Douglas ; Mitchell, Leah ; Yagiz, Kader...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi252-vi252 , 2017

Link: https://doi.org/10.1093/..

12

Toca 511 gene transfer and treatment with the prodrug, 5-fl..:

Mitchell, Leah A. ; Lopez Espinoza, Fernando ; Mendoza, Daniel...
Neuro-Oncology. 19 (2017) 7 - p. 930-939 , 2017

Link: https://doi.org/10.1093/..

13

ATIM-21. INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH ..:

Walbert, Tobias ; Bota, Daniela ; Vogelbaum, Michael...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi30-vi31 , 2017

Link: https://doi.org/10.1093/..

14

Regulation of Cannabinoid‐mediated Neuroprotection by Hydro..:

Mitchell, Leah ; Robinson, Jenaye ; Ngele, Kalu...
The FASEB Journal. 31 (2017) S1 - p. , 2017

Link: https://doi.org/10.1096/..

15

SCDT-06. QUANTIFIABLE LEVELS OF THE TRANSGENE, CYTOSINE DEA..:

Walbert, Tobias ; Bota, Danilella ; Vogelbaum, Michael...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi265-vi266 , 2017

Link: https://doi.org/10.1093/..